(Q41441897)

30 September 2017

1 reference

title

Tourette syndrome. Treatment of tics (English)

1 reference

30 September 2017

Kurlan R

1

1 reference

30 September 2017

publication date

1 May 1997

1 reference

30 September 2017

1 reference

30 September 2017

volume

15

1 reference

30 September 2017

issue

2

1 reference

30 September 2017

page(s)

403-409

1 reference

Habit reversal for the treatment of Tourette syndrome

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970321-2

7 January 2021

Gilles de la Tourette's syndrome, tardive dyskinesia, and psychosis in an adolescent

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970321-2

7 January 2021

Tardive dyskinesia in persons with Gilles de la Tourette's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970321-2

7 January 2021

TOURETTE'S DISEASE: SYMPTOMATIC RELIEF WITH HALOPERIDOL

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970321-2

7 January 2021

Clonidine ameliorates Gilles de la Tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970321-2

7 January 2021

A four-step hypnotherapy model for Gilles de la Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970321-2

7 January 2021

A controlled trial of deprenyl in children with Tourette's syndrome and attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970321-2

7 January 2021

ECG changes during haloperidol and pimozide treatment of Tourette's disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970321-2

7 January 2021

Treatment of Tourette's syndrome with transdermal clonidine: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970321-2

7 January 2021

Fluphenazine and multifocal tic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970321-2

7 January 2021

Clonidine and Gilles de la Tourette's syndrome: double-blind study using objective rating methods

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970321-2

7 January 2021

Effect of tetrabenazine on tics and sleep of Gilles de la Tourette's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970321-2

7 January 2021

Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970321-2

7 January 2021

Deprenyl in attention deficit associated with Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970321-2

7 January 2021

Botulinum toxin in the treatment of dystonic tics

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970321-2

7 January 2021

A case of Gilles de la Tourette's syndrome treated with clonazepam.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970321-2

7 January 2021

Neurosurgical treatment of severe obsessive-compulsive disorder associated with Tourette's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970321-2

7 January 2021

Short- and long-term treatment of Tourette's syndrome with clonidine: a clinical perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970321-2

7 January 2021

Clonidine treatment of Gilles de la Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970321-2

7 January 2021

Gilles de la Tourette's disease. A clinical study of fifteen cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970321-2

7 January 2021

The effects of nicotine plus haloperidol compared to nicotine only and placebo nicotine only in reducing tic severity and frequency in Tourette's disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970321-2

7 January 2021

Blood choline and response to clonazepam and haloperidol in Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970321-2

7 January 2021

School avoidance and social phobia triggered by haloperidol in patients with Tourette's disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970321-2

7 January 2021

Haloperidol-induced tardive dyskinesia in a child with Gilles de la Tourette's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970321-2

7 January 2021

Clinical features and long-term treatment with pimozide in 65 patients with Gilles de la Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970321-2

7 January 2021

Tardive dyskinesia following haloperidol treatment in Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970321-2

7 January 2021

Management of Gilles de la Tourette syndrome using sulpiride.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970321-2

7 January 2021

The treatment of Gilles de la Tourette syndrome by limbic leucotomy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970321-2

7 January 2021

Comparison of pimozide with haloperidol in Gilles de la Tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970321-2

7 January 2021

A comparison of pimozide and haloperidol in the treatment of Gilles de la Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970321-2

7 January 2021

Nicotine potentiates the effects of haloperidol in animals and in patients with Tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970321-2

7 January 2021

Treatment of Gilles de la Tourette's Syndrome with haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970321-2

7 January 2021

Treatment of Gilles de la Tourette syndrome with pimozide

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970321-2

7 January 2021

Treatment of Tourette disorder with penfluridol

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970321-2

7 January 2021

Treatment of Gilles de la Tourette's Syndrome With Clonidine and Neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970321-2

7 January 2021

Controlled Study of Pimozide vs. Placebo in Tourette's Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970321-2

7 January 2021

Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970321-2

7 January 2021

Tardive dystonia in patients with Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970321-2

7 January 2021

Calcium antagonists in the treatment of Tourette's disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970321-2

7 January 2021

A new hypnobehavioral method for the treatment of children with Tourette's disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970321-2

7 January 2021

10.1016/S0733-8619(05)70321-2

Identifiers

DOI

1 reference

30 September 2017

1 reference